GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EuBiologics Co Ltd (XKRX:206650) » Definitions » Total Long-Term Assets

EuBiologics Co (XKRX:206650) Total Long-Term Assets : ₩115,300 Mil (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is EuBiologics Co Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. EuBiologics Co's Total Long-Term Assets for the quarter that ended in Sep. 2024 was ₩115,300 Mil.


EuBiologics Co Total Long-Term Assets Historical Data

The historical data trend for EuBiologics Co's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EuBiologics Co Total Long-Term Assets Chart

EuBiologics Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Long-Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 75,334.27 84,548.41 96,717.88 120,927.21 110,041.67

EuBiologics Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 129,837.19 110,041.67 109,897.34 111,661.93 115,299.91

EuBiologics Co Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.


EuBiologics Co Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of EuBiologics Co's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


EuBiologics Co Business Description

Traded in Other Exchanges
N/A
Address
6F Bomnal-A-Chim B/D Mabang-ro 8, Seocho-gu, Seoul, KOR, 06778
EuBiologics Co Ltd is a biopharmaceutical company, which develops and supplies vaccines for epidemics and antibiotic resistance in South Korea. It offers Euvchol, an oral cholera prevention vaccine; and CRM197, a diphtheria toxin mutant vaccine, Inaba Cairo, and among others.

EuBiologics Co Headlines

No Headlines